Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Ketamine hydrochloride may lessen neuropathic pain in patients with cancer. It is
not yet known whether ketamine hydrochloride given together with the best pain management is
more effective than a placebo given together with the best pain management in treating
neuropathic pain in patients with cancer.
PURPOSE: This randomized phase III trial is studying ketamine hydrochloride given together
with the best pain management to see how well it works compared with giving a placebo
together with the best pain management in treating cancer patients with neuropathic pain.